Novartis’ (NVS) Motion to Block Entresto Generic Denied: What’s Next?
ZacksNovartis’ (NVS) efforts to ward off generic competition for its top cardiovascular drug, Entresto, face a setback.
Novartis’ (NVS) efforts to ward off generic competition for its top cardiovascular drug, Entresto, face a setback.